Antibiotice S.A. (BVB:ATB)
Romania
· Delayed Price · Currency is RON 2.425
+0.005 (0.21%)
At close: Jun 27, 2025
Antibiotice Revenue
Antibiotice had revenue of 163.87M RON in the quarter ending March 31, 2025, a decrease of -11.89%. This brings the company's revenue in the last twelve months to 666.58M, up 7.70% year-over-year. In the year 2024, Antibiotice had annual revenue of 688.70M with 11.93% growth.
Revenue (ttm)
666.58M
Revenue Growth
+7.70%
P/S Ratio
2.44
Revenue / Employee
491.58K
Employees
1,357
Market Cap
1.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 688.70M | 73.41M | 11.93% |
| Dec 31, 2023 | 615.29M | 110.29M | 21.84% |
| Dec 31, 2022 | 505.00M | 126.17M | 33.31% |
| Dec 31, 2021 | 378.83M | 31.60M | 9.10% |
| Dec 31, 2020 | 347.22M | -47.92M | -12.13% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| S.P.E.E.H. Hidroelectrica | 8.52B |
| OMV Petrom | 34.60B |
| Banca Transilvania | 9.68B |
| SNGN Romgaz | 8.04B |
| BRD - Groupe Société Générale | 3.93B |
| S.N. Nuclearelectrica | 5.14B |
| Digi Communications | 12.14B |
| S.N.T.G.N. Transgaz | 4.63B |